10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          This study aimed to investigate the prevalence of HIV late presentation and advanced HIV disease and to identify the factors associated with HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in the Guangxi Zhuang Autonomous Region, in Southwestern China.

          Methods

          Patients with newly diagnosed HIV registered in the HIV surveillance system of Guangxi Centers for Disease Control between January 2012 and December 2016 were included in this study.

          Results

          Of 45,118 newly diagnosed patients, 70.2% had late presentation, and 45.1% had advanced HIV disease. A higher prevalence of late presentation and advanced HIV disease was found in male heterosexuals and female people who use drugs (PWID). Heterosexuals (OR 2.11 [95% CI 1.90–2.34]) and PWID (OR 1.55 [95% CI 1.30–1.84]) had a higher risk of late presentation than men who have sex with men (MSM). Blood testing of the blood receivers (OR 1.75 [95% CI 1.36–2.26]) and diagnosed in hospital (OR 1.74 [95% CI 1.65–1.84]) had an increased risk of late presentation compared to those who diagnosis in voluntary counseling and testing (VCT). Heterosexuals (OR 2.86 [95% CI 2.51–3.27]), PWID (OR 2.23 [95% CI 1.83–2.71]), blood testing of the blood receivers (OR 1.58 [95% CI 1.29–1.94]) and diagnosed in hospital (OR 1.85 [95% CI 1.76–1.94]) were also independent risk factors associated with advanced HIV disease. Older age, lower level of education and being divorced or widowed were also associated with late presentation and advanced HIV disease.

          Conclusions

          Late presentation and advanced HIV disease were very common among patients with newly diagnosed HIV in Guangxi, China during 2012–2016. Targeted programs are urgently required to reduce HIV late diagnosis in Guangxi, especially for male heterosexuals, PWID, and patients with characteristics such as older age, lower level of education, divorced or widowed.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

          These recommendations for human immunodeficiency virus (HIV) testing are intended for all health-care providers in the public and private sectors, including those working in hospital emergency departments, urgent care clinics, inpatient services, substance abuse treatment clinics, public health clinics, community clinics, correctional health-care facilities, and primary care settings. The recommendations address HIV testing in health-care settings only. They do not modify existing guidelines concerning HIV counseling, testing, and referral for persons at high risk for HIV who seek or receive HIV testing in nonclinical settings (e.g., community-based organizations, outreach settings, or mobile vans). The objectives of these recommendations are to increase HIV screening of patients, including pregnant women, in health-care settings; foster earlier detection of HIV infection; identify and counsel persons with unrecognized HIV infection and link them to clinical and prevention services; and further reduce perinatal transmission of HIV in the United States. These revised recommendations update previous recommendations for HIV testing in health-care settings and for screening of pregnant women (CDC. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR 1993;42[No. RR-2]:1-10; CDC. Revised guidelines for HIV counseling, testing, and referral. MMWR 2001;50[No. RR-19]:1-62; and CDC. Revised recommendations for HIV screening of pregnant women. MMWR 2001;50[No. RR-19]:63-85). Major revisions from previously published guidelines are as follows: For patients in all health-care settings HIV screening is recommended for patients in all health-care settings after the patient is notified that testing will be performed unless the patient declines (opt-out screening). Persons at high risk for HIV infection should be screened for HIV at least annually. Separate written consent for HIV testing should not be required; general consent for medical care should be considered sufficient to encompass consent for HIV testing. Prevention counseling should not be required with HIV diagnostic testing or as part of HIV screening programs in health-care settings. For pregnant women HIV screening should be included in the routine panel of prenatal screening tests for all pregnant women. HIV screening is recommended after the patient is notified that testing will be performed unless the patient declines (opt-out screening). Separate written consent for HIV testing should not be required; general consent for medical care should be considered sufficient to encompass consent for HIV testing. Repeat screening in the third trimester is recommended in certain jurisdictions with elevated rates of HIV infection among pregnant women.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.

            V Moyer (2013)
            Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for HIV. The USPSTF reviewed new evidence on the effectiveness of treatments in HIV-infected persons with CD4 counts greater than 0.200 × 109 cells/L; effects of screening, counseling, and antiretroviral therapy (ART) use on risky behaviors and HIV transmission risk; and long-term cardiovascular harms of ART. These recommendations apply to adolescents, adults, and pregnant women. The USPSTF recommends that clinicians screen adolescents and adults aged 15 to 65 years for HIV infection. Younger adolescents and older adults who are at increased risk should also be screened. (Grade A recommendation)The USPSTF recommends that clinicians screen all pregnant women for HIV, including those who present in labor who are untested and whose HIV status is unknown. (Grade A recommendation).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy.

              Ensuring timely access to care for persons with HIV is an important public health goal. To identify factors associated with delayed presentation to medical care after testing HIV-positive or with late HIV testing, we studied 968 patients at their first HIV care visit, enrolled in a multicenter study in Italy from 1997-2000. Patients completed a questionnaire on HIV-testing history, sexual behavior, and drug use behavior. Delayed presenters were patients with >6 months between their first HIV-positive test and presentation for HIV care; late testers were patients with CD4 count < 200 /mm or clinically defined AIDS at their first HIV-positive test. Among the study patients, 255 (26.3%) were delayed presenters, and 280 (28.9%) were late testers. In multinomial logistic regression analysis, injection drug use significantly increased (odds ratio [OR]= 5.04) the probability of delayed presentation but reduced (OR = 0.55) the chance of late testing. A previous HIV-negative test was associated with a reduced risk of both delayed presentation (OR = 0.39) and late testing (OR = 0.36). Unemployment was positively associated with delayed presentation and increasing age with late testing, whereas HIV counseling at the time of first positive HIV test strongly (OR = 0.42) reduced the odds of delayed presentation. Interventions aimed at promoting timely access to care of HIV-infected persons should consider differentiated programs for delayed presentation and late testing.
                Bookmark

                Author and article information

                Contributors
                huxi@stu.gxmu.edu.cn
                liangbingyu@gxmu.edu.cn
                zcx0420@163.com
                jiangjunjun@gxmu.edu.cn
                jieganghuang@gxmu.edu.cn
                ningchuanyi@gxmu.edu.cn
                liujie@gxmu.edu.cn
                gxzhoubo520@126.com
                zangninggxnn@163.com
                laijingzhen@stu.gxmu.edu.cn
                chenrongfeng20150617@outlook.com
                liaoyanyan@gxmu.edu.cn
                gxpan8788@163.com
                liuxin@stu.gxmu.edu.cn
                lgh605@163.com
                penxianwu@163.com
                86-771-5344361 , yeli@gxmu.edu.cn
                86-771-2518791 , shenzhiyong99999@sina.com
                86-771-5323713 , lianghao@gxmu.edu.cn
                Journal
                AIDS Res Ther
                AIDS Res Ther
                AIDS Research and Therapy
                BioMed Central (London )
                1742-6405
                16 March 2019
                16 March 2019
                2019
                : 16
                : 6
                Affiliations
                [1 ]ISNI 0000 0004 1798 2653, GRID grid.256607.0, Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, , Guangxi Medical University, ; Nanning, 530021 Guangxi China
                [2 ]ISNI 0000 0004 1798 2653, GRID grid.256607.0, Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, , Guangxi Medical University, ; Nanning, 530021 Guangxi China
                [3 ]ISNI 0000 0000 8803 2373, GRID grid.198530.6, Institute of HIV/AIDS Prevention and Control, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, ; Nanning, 530200 Guangxi China
                Article
                221
                10.1186/s12981-019-0221-7
                6420760
                30876476
                3c897073-9427-4ef6-8a3d-fc851b1bb99b
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 26 December 2018
                : 2 March 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81560326
                Award ID: 81660334
                Award ID: 31860040
                Award ID: 81803295
                Award ID: 81860655
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004607, Natural Science Foundation of Guangxi Province;
                Award ID: 2018GXNSFAA138070
                Award ID: 2018GXNSFAA138002
                Award ID: 2016GXNSFBA380189
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100002858, China Postdoctoral Science Foundation;
                Award ID: 2018M640890
                Award ID: 2018M643382
                Award Recipient :
                Funded by: Guangxi Science Foundation for Distinguished Young Scholars
                Award ID: 2018JJG140004
                Award Recipient :
                Funded by: Guangxi Science Foundation
                Award ID: 2018JJA140536
                Funded by: Scientific Research and Technology Development Program of Guangxi (CN)
                Award ID: Gui Jiao Ren 2014[7]
                Funded by: Science Foundation for The Excellent Young Scholars of Guangxi Collaborative Innovation Center for Biomedicine
                Award ID: GCICB-TC-2017015
                Award ID: GCICB-TC-2017004
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                Infectious disease & Microbiology
                late presentation,advanced hiv disease,hiv/aids,southwestern china

                Comments

                Comment on this article